Login to Your Account



EU Biosimilar Debate Moves to Use in Clinical Practice

By Nuala Moran


Wednesday, May 28, 2008
LONDON - With the first generic biologics reaching the market in Europe, the focus has shifted from arguments about how to approve them, to how the products should be used in clinical practice. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription